Biotech’s New Cycle, JPM Deal Hype and Where Alpha Still Hides
In this episode of Denatured, Jennifer C. Smith-Parker speaks with RTW’s Rod Wong and Stephanie Sirota how shifting JPM deal timing masks record M&A potential; why oncology, obesity, psychedelics, and neuroscience are attracting fresh capital; and how “alpha stacking” shapes their investment edge in an age of chronic uncertainty. They cover topics discussed in RTW's new book, "Innovation is the Best Medicine."
Hosts
Jennifer Smith-Parker, Director of Insights, BioSpace
Guests
Roderick Wong, Managing Partner, Chief Investment Officer, RTW Investments
Stephanie Sirota, Partner, Chief…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.